Active Biotech AB (publ) (STO:ACTI)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0708
-0.0010 (-1.39%)
May 21, 2026, 12:58 PM CET

Active Biotech AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
53.365.127.436.2241.853.13
Cash & Short-Term Investments
53.365.127.436.2241.853.13
Cash Growth
103.44%137.63%-24.36%-13.35%-21.34%102.70%
Other Receivables
2.71.49.51.260.951.19
Receivables
2.71.49.51.260.951.19
Prepaid Expenses
-1.082.321.241.381.53
Total Current Assets
5667.5839.2138.7144.1255.86
Property, Plant & Equipment
1.62.023.354.726.260.95
Other Intangible Assets
0.20.250.250.250.25-
Other Long-Term Assets
0.40.380.380.380.380
Total Assets
58.270.2143.1844.0551.0156.8
Accounts Payable
-4.921.453.173.532.76
Accrued Expenses
-7.685.445.366.375.98
Current Portion of Leases
-1.611.651.551.610.76
Other Current Liabilities
10.90.280.360.30.560.41
Total Current Liabilities
10.914.478.9110.3812.069.9
Long-Term Debt
0.1-----
Long-Term Leases
-0.131.5334.430.23
Total Liabilities
1114.610.4413.3816.4910.13
Common Stock
47.213.616.351.871.371.13
Additional Paid-In Capital
-3,5623,5093,4723,4313,386
Retained Earnings
--3,520-3,483-3,443-3,398-3,340
Shareholders' Equity
47.255.6132.7430.6734.5146.67
Total Liabilities & Equity
58.270.2143.1844.0551.0156.8
Total Debt
0.11.743.184.556.040.99
Net Cash (Debt)
53.263.3624.2131.6735.7652.15
Net Cash Growth
111.95%161.72%-23.56%-11.42%-31.43%115.38%
Net Cash Per Share
0.030.050.060.120.150.24
Filing Date Shares Outstanding
2,6362,6361,230361.74264.89217.97
Total Common Shares Outstanding
2,6362,6361,066361.74264.89217.97
Working Capital
45.153.1130.328.3332.0645.95
Book Value Per Share
0.020.020.030.080.130.21
Tangible Book Value
4755.3732.530.4234.2746.67
Tangible Book Value Per Share
0.020.020.030.080.130.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.